Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Hatzl Stefan |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Prattes, J; Giacobbe, DR; Marelli, C; Singnori, A; Cattardico, G; Hatzl, S; Reisinger, AC; Eller, P; Krause, R; Reizine, F; Bassetti, M; Gagneux, JP; Hoenigl, M Posaconazole for prevention of COVID-19 associated pulmonary aspergillosis in mechanically ventilatet patients: A European multicenter case-control study (POSACOVID)
58th Scientific Conference of the German speaking Mycological Society (DMykG) ; SEP 17-20, 2024; Jena, GERMANY. 2024. [Oral Communication]

 

Puseljic, M; Schmid, J; Igrec, J; Hatzl, S; Scholz, L; Wölfler, A; Fuchsjäger, M; Talakic, E Seltene pulmonale Manifestationen des VEXAS-Syndroms.
DOI 10.1055/s-0044-1781741 Fortschr Röntgenstr . 2024; 196: S1–S127: 112-113.-105. DEUTSCHER RÖNTGENKONGRESS 10. GEMEINSAMER KONGRESS VON DRG UND ÖRG; MAY 8-10; Wiesbaden, DEUTSCHLAND. [Oral Communication]
FullText

 

Scholz, L; Stelzl, A; Schlager, H; Konrad, J; Blesl, A; Hauser, A; Reisinger, A; Eller, P; Hatzl, S; Kolland, M; Baumann-Durchschein, F Spontaneous mucosal tear in lymphocytic esophagitis-A case report
MED KLIN-INTENSIVMED. 2024; 119(5): 441-441. [Poster]
Web of Science

 

Schloffer, L; Neumeister, P; Greinix, HT; Hatzl, S; Schulz, E Outcome of Adult Patients with Acute Lymphoblastic Leukemia Treated in Graz Between 2001 to 2021
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. memo. 2023; 16(Suppl1):S1--Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 30 - APR 1, 2023; Innsbruck, Austria. [Poster]
FullText

 

Scholz, L; Posch, F; Schulz, E; Gornicec, M; Rosenkranz, AR; Schilcher, G; Krause, R; Hatzl, S Ruxolitinib, Intravenous Immunoglobulin and High-Dose Corticosteroids in the Management of Critically Ill Adult Patients with Hemophagocytic Lymphohistiocytosis
41. Wiener Intensivmedizinische Tage ; FEB 15-18, 2023; Vienna, AUSTRIA. 2023. [Oral Communication]

 

Scholz, L; Posch, F; Schulz, E; Gornicec, M; Rosenkranz, AR; Schilcher, G; Reisinger, A; Krause, R; Hatzl, S Ruxolitinib, intravenous immunoglobulin and high-dose corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis
MED KLIN-INTENSIVMED. 2023; 118(5): [Oral Communication]
Web of Science

 

Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Krassnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P Pathogen detection by metagenomic next-generation sequencing during neutropenic fever in patients with haematological malignancies
BRIT J HAEMATOL. 2023; 201: 21-22.-63rd Annual Scientific Meeting of the British-Society-for-Haematology; APR 23-25, 2023; Birmingham, ENGLAND. [Poster]
Web of Science

 

Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
ÖGR Jahrestagung 2022; NOV 3-5, 2022; Vienna, AUSTRIA. 2022. [Poster]

 

Kriegl L, Hatzl S, Zurl C, Reisinger A, Schilcher G, Eller P, Gringschl Y, Muhr T, Meinitzer A, Prattes J, Hönigl M, Krause R Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation
56. Wissenschaftliche Tagung der Deutschsprachigen Mykologischen Gesellschaft; 12.-14.09.2022; Wien, Österreich. 2022. [Oral Communication]

 

Ribitsch, W; Wagner, F; Meinitzer, A; Pflanzl-Knizacek, L; Hafner, M; Hatzl, S; Eller,P; Mursic, I; Toller, W; Schörghuber, M; Queisser, L; Zitta, S; Schilcher, G; Diskrepantes Verhalten zwischen der errechneten und der gemessenen glomerulären Filtrationsrate nach herzchirurgischen Eingriffen
https://d2t0unnjxes6lt.cloudfront.net/data/nephrologie/data/assets/2022/ Abstractband.pdf. 2022; -14. Jahrestagung der Deutschen Gesellschaft für Nephrologie; Oct 6-9, 2022; Berlin, Germany. [Poster]
FullText

 

Berg, JL; Perfer, B; Hatzl, S; Reinisch, A; Pregartner, G; Klymiuk, I; Tierling, S; Geissler, G; Strobl, H; Berghold, A; Wölfer, A; Sill, H; Zebisch, A Aberrant expression of micro-RNA-125a plays a role in the pathogenesis and treatment of chronic myelomonocytic leukemia – Update
memo - Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2021; 14: -Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 8-10, 2021; Wien. [Poster]

 

Berg, JL; Perfler, B; Hatzl, S; Reinisch, A; Geissler, K; Strobl, H; Wölfler, A; Sill, H; Zebisch, A Expression of miR-125a is decreased in chronic myelomonocytic leukemia and of relevance for the treatment with 5-azacytidine
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology, Magazine of European Medical Oncology. 2019; 12: 53--Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 11-13, 2019; Linz, AUSTRIA. [Poster]

 

Gornicec, M; Reinisch, A; Hatzl, S; Schilcher, G; Wölfler, A; Schulz, E Sustained complete remission with Ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis: a case report
Oncol Res Treat 2019;42(suppl 4):1-336. 2019; -Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 11-14, 2019; Berlin, GERMANY. [Poster]
FullText

 

Uhl, B; Prochazka, K; Wenzl, K; Hatzl, S; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, A Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome
ONCOL RES TREAT. 2019; 42: 83-83. [Poster]
Web of Science

 

Aberer, F.; Manninger-Wünscher, M; Rainer, F.; Artinger, K.; Rehatschek, H.; Hye, F.; Pieber, Th. R.; Fickert, P.; Hammer, H.; Lang-Loidolt, D.; Roller-Wirnsberger, R.; Teaching of Clinical Reasoning in Internal Medicine in Blended Learning format integrated in the Curriculum of the Medical University of Graz
In proceedings of the 22nd Grazer conference. 2018; 40-41.-Grazer Konferenz; APR 5-7, 2018; Maribor, Slovenia. (ISBN: 978-3-200-05654-1 ) [Poster]
FullText

 

Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Wolfler, A; Sill, H; Zebisch, A Loss of RKIP expression is a frequent event in chronic myelomonocytic leukemia and functionally involved in the pathogenesis of this malignancy
ONCOL RES TREAT. 2018; 41: 27-27. [Oral Communication]
Web of Science

 

Hatzl, S; Ebner, S; Perfler, B; Quehenberger, F; Troppmair, J; Reinisch, A; Wolfler, A; Sill, H; Zebisch, A Deregulation of the micro-RNA-23a/TOP2B axis causes resistance to cytarabine in acute myeloid leukemia
ONCOL RES TREAT. 2018; 41: 243-243. [Oral Communication]
Web of Science

 

Hatzl, S; Ebner, S; Perfler, B; Quehenberger, F; Troppmair, J; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A Increased expression of micro-RNA-23a causes resistance to cytarabine in acute myeloid leukemia.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology . 2018; Supplement 1/18: 26-26.-Annual Meeting of the Austrian Society for Hematology and Medical Oncology; APR, 19-21, 2018; Villach, AUSTRIA. [Oral Communication]

 

Hatzl, S; Kreuzer, P; Lueger, A; Eisner, F; Uhl, B; Jud, P; Tension hydropneumothorax after transbronchial lung biopsy
9. Kongress der Arbeitsgemeinschaft für Notfallmedizin; APR 5-7, 2018; Graz, AUSTRIA. 2018. [Poster]

 

Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Woelfler, A; Sill, H; Zebisch, A LOSS OF RAF KINASE INHIBITOR PROTEIN IS INVOLVED IN MYELOMONOCYTIC LINEAGE COMMITMENT AND AGGRAVATES THE DEVELOPMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN A MURINE IN-VIVO MODEL
HAEMATOLOGICA. 2017; 102: 148-149.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN. [Oral Communication]
Web of Science

 

Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, P; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Wölfler, A; Sill, H; Zebisch, A RAF kinase inhibitor protein is involved in the development of chronic myelomonocytic leukemia
memo - Magazine of European Medical Oncology. 2017; 10(2):21-21.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 6-8, 2017; Bregenz, AUSTRIA. [Poster]

 

Hatzl, S; Geiger, O; Kuepper, MK; Seime, T; Nußbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Wölfler, A; Troppmair, J; Sill, H; Zebisch, A Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a
Oncology Research and Treatment. 2015; 38: -Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OKT 9-13, 2015; Basel, SWITZERLAND. (ISBN: 978-3-318-02811-9 ) [Oral Communication]

 

Hatzl, S; Geiger, O; Kuepper, MK; Seime, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Wolfler, A; Troppmair, J; Sill, H; Zebisch, A Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a
ONCOL RES TREAT. 2015; 38: 99-99. [Oral Communication]
Web of Science

 

Hatzl, S; Geiger, O; Nußbaumer, E; Rosenberger, A; Troppmair, J; Kolch, W; Blyth, K; Sill, H; Woelfler, A; Zebisch, A RAF kinase inhibitor protein is involved in the myelomonocytic differentiation of hematopoietic progenitors.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(S1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, AUSTRIA. [Poster]

 

Milewska, M; Romano, D; Guerriero, ML; Birtwistle, M; Quehenberger, F; Hatzl, S; Herrero-Mier, A; Kholodenko, BN; Segatto, N; Kolch, W; Zebisch, A Mitogen-inducible gene-6 inhibits malignant transformation of mutated BRAF by mediating feedback inhibition towards the epidermal growth factor receptor.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, AUSTRIA. [Poster]

 

Nußbaumer, E; Hatzl, S; Kuepper, K; Geiger, O; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Lavrencic, M; Woelfler, A; Troppmair, J; Sill, H; Zebisch, A Loss of RAF kinase inhibitor protein in acute myeloid leukemia is caused by the overexpression of miRNA-15a.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, VIENNA. [Poster]

 

Simone, G; De Nunzio, C; Sperduti, I; Cindolo, L; Collura, D; Brookman-May, S; Papalia, R; Ferriero, M; Leonardo, C; Dalpiaz, O; Hatzl, S; Lodde, M; Trenti, E; Pastore, A; Palleschi, G; Lotrecchiano, G; Salzano, L; Carbone, A; De Cobelli, O; Tubaro, A; Schips, L; Zigeuner, R; Muto, G; Gallucci, M Trends in the use of partial nephrectomy for cT1 renal tumours: Analysis of a 10-yr European multicenter dataset
European Urology supplements. 2015; 14(2):101-101.-30th Annual EAU Congress; MAR 20-24, 2015; Madrid, SPAIN. [Poster]

 

Simone, G; De Nunzio, C; Sperduti, I; Cindolo, L; Collura, D; Brookman-May, S; Papalia, R; Ferriero, M; Leonardo, C; Dalpiaz, O; Lodde, M; Trenti, E; Hatzl, S; Pastore, A; Palleschi, G; Lotrecchiano, G; Salzano, L; Carbone, A; De Cobelli, O; Tubaro, A; Schips, L; Zigeuner, R; Muto, G; Gallucci, M Trends in the use of partial nephrectomy for cT1 renal tumors: analysis of a 10-yr european multicenter dataset
J Urol suppl. 2015; 193(4):e974-e974.-AUA Annual Meeting ; MAY 15-19,2015; New Orleans, USA. [Poster]

 

Zebisch, A; Schulz, E; Hatzl, S; Grosso, M; Lombardo, B; Acierno, G; Sill, H; Iolascon, A Epsilon-gamma-delta-beta° thalassemia Austrian I: identification of a novel hemoglobinopathy.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, AUSTRIA. [Poster]

 

Zebisch, A; Wolf, O; Rosenberger, A; Petricevic, P; Hatzl, S; Troppmair, J; Kolch, W; Blyth, K; Haller, M; Sill, H; Woelfler, A RAF kinase inhibitor protein is involved in the regulation of myelomonocytic differentiation.
Oncol Res Treat. 2014; 37(S5):49-49. 2014; 37(S5):24-24.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14; Hamburg. (ISBN: 978-3-318-0281 ) [Oral Communication]
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum